The UNC/Emory Center for Innovative Technology (iTech) across the prevention and care continuum
北卡罗来纳大学/埃默里大学创新技术中心 (iTech) 涵盖预防和护理连续体
基本信息
- 批准号:10399185
- 负责人:
- 金额:$ 400万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-06-01 至 2022-11-30
- 项目状态:已结题
- 来源:
- 关键词:AIDS preventionAIDS/HIV problemAddressAdherenceAdolescentAdolescent and Young AdultAgeApplications GrantsAreaBehavioralCollaborationsCommunicationCommunitiesContinuity of Patient CareDevelopmentDisciplineEarly identificationEarly treatmentEnsureEnvironmentEpidemicEpidemiologyEvaluationFosteringGoalsHIVHIV InfectionsHIV diagnosisHuman immunodeficiency virus testInfectionInfrastructureInterdisciplinary StudyInterventionLeadershipMental HealthMentorsMissionPilot ProjectsPreventionResearchResearch PersonnelResearch Project GrantsResourcesRiskStigmatizationStructureTechnologyTherapeuticTrainingUnited StatesUnited States National Institutes of HealthViralWorkYouthage groupagedantiretroviral therapybasecare systemscommunity engagementdesignexperienceinnovationinnovative technologiesmen who have sex with menmicrobicideprevention serviceprogramsrecruitsubstance usesuccesssynergismtechnological innovationtherapy designtreatment as preventionuptakevaccine trialyoung men who have sex with men
项目摘要
While the epidemic of HIV in the US has leveled off for many age groups, from 2000-2010, the annual number
of new HIV diagnoses among young men who have sex with men (YMSM) (13-24 year old) more than
doubled. In 2010, YMSM accounted for 72% of new infections among people ages 13 to 24, and 30% of all
new infections among MSM. The success of treatment as prevention in reducing the number of new HIV
infections among youth, and particularly YMSM, relies on HIV testing, antiretroviral treatment (both for
treatment and prevention), adherence and viral suppression among those with HIV. The UNC/Emory Center
for Innovative Technology (iTech) aims to impact the HIV epidemic by conducting innovative, interdisciplinary
research on technology-based interventions across the HIV prevention and care continuum for adolescents
and young adults in the United States (US). The iTech also creates an infrastructure to share and disseminate
best practices in technology-delivered HIV interventions to other ATN projects and programs serving
adolescents. The iTech overall goals seek to decrease the impact of HIV on the lives of adolescents and young
adults in the US, particularly YMSM, by providing: 1) treatment as prevention for those without HIV but at risk;
2) earlier identification and treatment for those infected but undiagnosed; 3) interventions to address structural
determinants that decrease access to and uptake of prevention and care services; and 4) treatment
interventions to encourage adherence for youth dealing with substance use, mental health related issues,
stigmatization and disenfranchisement. The necessary resources and support for HIV/AIDS investigators
addressing these goals will be provided by the iTech Cores: 1) Management; 2) Analytic; and, 3) Technology.
To accomplish our Overall Goals we have developed the following Specific Aims: Aim 1: To provide scientific
leadership with expertise and experience in technology-based research to address fundamental questions
related to the HIV prevention and care continuum, guide our overall research strategy and foster collaboration
and synergy both within our iTech and with the broader ATN scientific community. Aim 2: To support the
development and assessment of innovative technology-focused interventions addressing the HIV
prevention and care continuum for at-risk or infected youth aged 15-24 years. Aim 3: To support the overall
ATN scientific agenda by participating on the ATN Executive Committee and collaborating with other U19
awardees stimulating new synergistic and responsive grants applications and research to respond to emerging
issues in this field. Aim 4: To develop and nurture partnerships that will ensure community input at all
stages of conceptualization, design, implementation, and interpretation of the research. Aim 5. To develop,
mentor and train clinicians and researchers to stimulate innovative HIV/AIDS research focused on
technological innovation across the care continuum.
虽然美国许多年龄组的艾滋病疫情已经趋于平稳,但从2000年到2010年,每年的感染人数都在下降
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lisa B Hightow-Weidman其他文献
Studying the Digital Intervention Engagement–Mediated Relationship Between Intrapersonal Measures and Pre-Exposure Prophylaxis Adherence in Sexual and Gender Minority Youth: Secondary Analysis of a Randomized Controlled Trial
研究数字干预参与度——性少数青年中人际测量与暴露前预防依从性之间的中介关系:一项随机对照试验的二次分析
- DOI:
10.2196/57619 - 发表时间:
2025-01-01 - 期刊:
- 影响因子:6.000
- 作者:
Michael P Williams;Justin Manjourides;Louisa H Smith;Crissi B Rainer;Lisa B Hightow-Weidman;Danielle F Haley - 通讯作者:
Danielle F Haley
Lisa B Hightow-Weidman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lisa B Hightow-Weidman', 18)}}的其他基金
Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Scientific Leadership Center
艾滋病毒/艾滋病干预青少年医学试验网络 (ATN) 科学领导中心
- 批准号:
10595899 - 财政年份:2023
- 资助金额:
$ 400万 - 项目类别:
Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN)Scientific Leadership Center; ADMIN SUPPLEMENT
艾滋病毒/艾滋病干预青少年医学试验网络 (ATN) 科学领导中心;
- 批准号:
10855435 - 财政年份:2023
- 资助金额:
$ 400万 - 项目类别:
PrEP Choice: Increasing the Use of HIV Pre-exposure Prophylaxis in an Era of Choices
PrEP 选择:在选择时代增加 HIV 暴露前预防的使用
- 批准号:
10775220 - 财政年份:2022
- 资助金额:
$ 400万 - 项目类别:
PrEP Choice: Increasing the Use of HIV Pre-exposure Prophylaxis in an Era of Choices
PrEP 选择:在选择时代增加 HIV 暴露前预防的使用
- 批准号:
10804710 - 财政年份:2022
- 资助金额:
$ 400万 - 项目类别: